CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Kelowna, Canada.
Company profile
CEO
Dominick Colvin
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
465526169
Latest filings (excl ownership)